 |
Sequence Source Links |  |
||||
|
||||||
 |
 |
|
Database Satistics | |
|
|
|||
|
|
|
|||
| What is attenuated vaccine ? | |||
| A virulent organism that has been modified to produce a less virulent form, but nevertheless retains the ability to elicit antibodies against the virulent form |
|||
| Dengue Serotype I | |||
S/No. |
Accession No. |
Patent | Reference |
1. |
JP 2002540169-A 2 26-NOV-2002; WALTER REED ARMY INSTITUTE OF RESEARCH |
||
2. |
JP 2002540169-A 1 26-NOV-2002; WALTER REED ARMY INSTITUTE OF RESEARCH |
||
1. |
JP 2002540170-A 2 26-NOV-2002; WALTER REED ARMY INSTITUTE OF RESEARCH |
||
2. |
JP 2002540170-A 1 26-NOV-2002; WALTER REED ARMY INSTITUTE OF RESEARCH |
||
1. |
JP 2002540171-A 1 26-NOV-2002; WALTER REED ARMY INSTITUTE OF RESEARCH |
||
2. |
JP 2002540171-A 2 26-NOV-2002; WALTER REED ARMY INSTITUTE OF RESEARCH |
||
| References | |||
| 17328799 | Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1. | ||
| 12502885 | A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeys. | ||
| Link | Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Δ30 with those of DEN1 | ||
| 15827166 | Recombinant, Live-Attenuated Tetravalent Dengue Virus Vaccine Formulations Induce a Balanced, Broad, and Protective Neutralizing Antibody Response against Each of the Four Serotypes in Rhesus Monkeys | ||
| 17012875 | The live attenuated dengue serotype 1 vaccine rDEN1Delta30 is safe and highly immunogenic in healthy adult volunteers. | ||
| 17012873 | Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes. | ||
| 16553547 | Development of a live attenuated dengue virus vaccine using reverse genetics. | ||
| 16087248 | Determining genetic stabilities of chimeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative TaqMAMA. | ||